These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 4331016

  • 1. Pathophysiology of hyperuricemia in primary gout.
    Wyngaarden JB.
    Trans Am Clin Climatol Assoc; 1970; 81():161-73. PubMed ID: 4331016
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic defects of primary hyperuricemia and gout.
    Wyngaarden JB.
    Am J Med; 1974 May; 56(5):651-64. PubMed ID: 4363475
    [No Abstract] [Full Text] [Related]

  • 3. Genetic aspects of gout.
    Becker MA, Seegmiller JE.
    Annu Rev Med; 1974 May; 25(0):15-28. PubMed ID: 4604505
    [No Abstract] [Full Text] [Related]

  • 4. Accelerated erythrocyte 5-phosphoribosyl-1-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout.
    Sperling O, Eilam G, Sara-Persky-Brosh, De Vries A.
    Biochem Med; 1972 Aug; 6(4):310-6. PubMed ID: 4340256
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Concentration and synthesis of phosphoribosylpyrophosphate in erythrocytes from normal, hyperuricemic, and gouty subjects.
    Meyskens FL, Williams HE.
    Metabolism; 1971 Aug; 20(8):731-42. PubMed ID: 4327978
    [No Abstract] [Full Text] [Related]

  • 10. The Jewish Hospital of St. Louis. Therapeutic grand rounds number 7. An approach to disorders of uric acid metabolism.
    Thier SO, Wessler S, Avioli LV.
    Arch Intern Med; 1974 Sep; 134(3):579-85. PubMed ID: 4855167
    [No Abstract] [Full Text] [Related]

  • 11. [Current biochemical acquisitions on pathogenesis of gout].
    Marcolongo R.
    Reumatismo; 1971 Sep; 23(3):109-25. PubMed ID: 5150688
    [No Abstract] [Full Text] [Related]

  • 12. Increased PP-ribose-P synthetase activity: a genetic abnormality leading to excessive purine production and gout.
    Becker MA, Meyer LJ, Kostel PJ, Seegmiller JE.
    Adv Exp Med Biol; 1973 Sep; 41():307-15. PubMed ID: 4364688
    [No Abstract] [Full Text] [Related]

  • 13. [Gout, archetype of diseases caused by deposits].
    Delbarre F, de Gery A.
    Ann Biol Clin (Paris); 1972 Sep; 30(6):637-67. PubMed ID: 4567260
    [No Abstract] [Full Text] [Related]

  • 14. Azaguanine-resistance as a manifestation of a new form of metabolic overproduction of uric acid.
    Benke PJ, Herrick N.
    Am J Med; 1972 Apr; 52(4):547-55. PubMed ID: 5017247
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibitors of purine metabolism in Ehrlich ascites tumor cells in vitro.
    Lau KF, Henderson JF.
    Cancer Chemother Rep 2; 1972 Nov; 3(1):95-109. PubMed ID: 4499907
    [No Abstract] [Full Text] [Related]

  • 17. Observations of altered intracellular phosphoribosylpyrophosphate (PP-ribose-P) in human disease.
    Fox IH, Kelley WN.
    Adv Exp Med Biol; 1974 Nov; 41():471-8. PubMed ID: 4364979
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.